Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Arthroplasty
NCT ID: NCT01545362
Last Updated: 2017-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2011-11-30
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Nutritional Status in Patients Undergoing Elective Total Knee Arthroplasty and In-hospital Postoperative Complications
NCT03549962
Knee Arthroplasty Registry
NCT01132365
Persistent Postoperative Pain and Joint Stiffness After Total Knee Arthroplasty Performed for Osteoarthritis
NCT02626533
An Artificial Intelligence-based Approach in Total Knee Arthroplasty: From Inflammatory Responses to Personalized Medicine
NCT06634654
Anterior Referencing Versus Posterior Referencing in Minimally Invasive Total Knee Arthroplasty
NCT01135030
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The goal was to evaluate the impact of the nutritional status on the outcomes of primary staged bilateral TKAs performed one-week apart during two separate hospitalizations.
Fifty consecutive patients with mean age of 67 years, mean BMI of 28.9 and 2.3 mean ASA score were followed for one year.
Prior to the first surgery 32% had a TLC \<1500 cells/mm3 and 84% had a SA \<3.5 g/dL. Before the second surgery 62% had a reduced TLC and all but one had a reduced SA.
Nine patients had a total of 12 perioperative blood transfusions (2 after the first surgery and 10 after the second surgery). The average length of stay was 3 days after each TKA.
None of the patients with the lowest TLC or SA before the first or the second stage had a revision.
Bilateral TKAs performed seven days apart in two separate hospitalizations is a safe and practical approach for qualified patients. The postoperative course was similar after each surgery. The preoperative nutritional status defined by TLC and SA did not influence the postoperative outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Staged bilateral total knee arthroplasty
Patients that have bilateral total knee arthroplasty staged within one week
Total knee arthroplasty
Total knee arthroplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total knee arthroplasty
Total knee arthroplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient requires a bilateral staged knee arthroplasty (within 7 days)
* Patient has signed and dated an IRB approved consent form.
* Patient is able and willing to participate in the study according to the protocol for the full length of expected term of follow-up, and to follow their physician's directions.
* Patient has failed to respond to conservative treatment modalities.
Exclusion Criteria
* Patient is a prisoner.
* Surgery on the second side cancelled or delayed past 7 days by patient request subject will be terminated from the study.
* BMI \>35
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heekin Orthopedic Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
R. David Heekin, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
R. David Heekin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Heekin Institute for Orthopedic Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heekin Orthopedic Specialists
Jacksonville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.